TG Therapeutics, Inc. (TGTX)
NASDAQ · Healthcare
TG Therapeutics, Inc. Total Liabilities 2016–2025
TG Therapeutics, Inc. annual total liabilities history from 2016 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- TG Therapeutics, Inc. total liabilities as of December 31, 2025: 415.2M, a 16.86% increase year-over-year.
- TG Therapeutics, Inc. total liabilities for 2025 were 415.2M, a 16.86% increase from 2024.
- TG Therapeutics, Inc. total liabilities for 2024 were 355.3M, a 110.15% increase from 2023.
- TG Therapeutics, Inc. total liabilities for 2023 were 169.1M, a 25.26% increase from 2022.
- TG Therapeutics, Inc. total liabilities for 2022 were 135.0M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| TG Therapeutics, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $415 |
| 2024 | $355 |
| 2023 | $169 |
| 2022 | $135 |
| 2021 | $142 |
| 2020 | $106 |
| 2019 | $124 |
| 2018 | $60 |
| 2017 | $30 |
| 2016 | $19 |
TG Therapeutics, Inc. Total Liabilities — FAQ
TG Therapeutics, Inc. (TGTX) total liabilities over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TGTX's total liabilities history?
The chart and table above show TG Therapeutics, Inc.'s total liabilities by year and by quarter, including the growth rate.